Skip to main content
Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA
  • Jacob E Robinson, University of Nebraska at Omaha
  • Christine E. Cutucache, University of Nebraska at Omaha
Document Type
Publication Date

Splenic marginal zone lymphoma (SMZL) is a malignancy of mature B-cells that primarily involves the spleen, but can affect peripheral organs as well. Even though SMZL is overall considered an indolent malignancy, the majority of cases will eventually progress to be more aggressive. In recent years, the gene expression profile of SMZL has been characterized in an effort to identify: 1) the etiology of SMZL, 2) biological consequences of SMZL, and 3) putative therapeutic targets. However, due to the vast heterogeneity of the malignancy, no conclusive target(s) have been deciphered. However, the role of miRNA in SMZL, much as it has in chronic lymphocytic leukemia, may serve as a guiding light. As a result, we review the comprehensive expression profiling in SMZL to-date, as well as describe the miRNA (and potential mechanistic roles) that may play a role in SMZL transformation, particularly within the 7q region.


Robinson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation Information
Jacob E Robinson and Christine E. Cutucache. "Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA" Oncotarget Vol. 9 Iss. 52 (2018) p. 30005 - 30022
Available at: